Vivos Therapeutics, Inc.
Hedge Funds Holdings

Last updated:

Vivos Therapeutics, Inc.‘s stocks are currently a part of 20 hedge funds’ portfolios, which represents 18.2% of the total amount of its stocks outstanding. This makes up a total of 3.86M shares of Vivos Therapeutics, Inc.. Compared to the previous quarter, the number grew by 146.91% or 2.29M shares more. As for the holding position changes, 20% (4) of current hedge fund investors increased the number of shares held, 15% (3) of current holders sold a part of the shares held, and 10% (2) closed the holdings completely. 6 hedge funds are new holders of Vivos Therapeutics, Inc. stock in Q1 2023, it is 30% of total holders.

Hedge funds holding Vivos Therapeutics (Q4 2020 – Q1 2023)

Number of hedge funds
Q4 2020 10
Q1 2021 17
Q2 2021 28
Q3 2021 37
Q4 2021 26
Q1 2022 26
Q2 2022 24
Q3 2022 26
Q4 2022 25
Q1 2023 20

Hedge funds changes in Vivos Therapeutics positions (Q4 2020 – Q1 2023)

Changes in positions
Q4 2020 100000
Q1 2021 13136-6
Q2 2021 16725-2
Q3 2021 181039-3
Q4 2021 291013-8
Q1 2022 71157-4
Q2 2022 45762
Q3 2022 63746
Q4 2022 65671
Q1 2023 64325

Hedge funds changes in Vivos Therapeutics stock options (Q4 2020 – Q1 2023)

Changes in stock options
Q4 2020 0 0
Q1 2021 0 0
Q2 2021 0 0
Q3 2021 707,000 568,000
Q4 2021 278,000 260,000
Q1 2022 91,000 126,000
Q2 2022 29,000 1,000
Q3 2022 11,000 0
Q4 2022 5,708 1,367
Q1 2023 0 0

Top 50 hedge fund holders of Vivos Therapeutics, Inc. (NASDAQ:VVOS)